"MultiCare Allenmore Hospital offers Tacoma residents convenient access to the latest diagnostic and treatment technologies, pharmacy, medical imaging and surgery center, plus a 24-hour Emergency Department all in a centrally located, patient-friendly campus in Central Tacoma."

During the past decade, Allenmore Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 68 clinical trials were completed, i.e. on average, 2266.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 18 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Allenmore Hospital" #1 sponsor was "SWOG Cancer Research Network" with 45 trials, followed by "National Cancer Institute (NCI)" with 29 trials sponsored, "Alliance for Clinical Trials in Oncology" with 10 trials sponsored, "NSABP Foundation Inc" with 7 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Allenmore Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 75 trials as a collaborator, "Cancer and Leukemia Group B" with 13 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator, "SWOG Cancer Research Network" with 9 trials as a collaborator and "North Central Cancer Treatment Group" with 8 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Allenmore Hospital" are "Breast Cancer" (19 trials), "Lung Cancer" (11 trials), "Lymphoma" (7 trials), "Recurrent Squamous Cell Lung Carcinoma" (6 trials) and "Recurrent Breast Carcinoma" (5 trials). Many other conditions were trialed in "Allenmore Hospital" in a lesser frequency.

Most popular intervention types in "Allenmore Hospital" are "Drug" (87 trials), "Other" (61 trials), "Biological" (39 trials), "Procedure" (13 trials) and "Radiation" (13 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (31 trials), "Quality-of-Life Assessment" (17 trials), "Paclitaxel" (15 trials), "Bevacizumab" (13 trials) and "cyclophosphamide" (12 trials). Other intervention names were less common.

The vast majority of trials in "Allenmore Hospital" are 73 trials for "All" genders, 31 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Allenmore Hospital". undefined are not yet recruiting, 1 are recruiting, 33 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 63 completed trials in Allenmore Hospital, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Allenmore Hospital, 0 "Phase 1" clinical trials were conducted, 29 "Phase 2" clinical trials and 72 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".